Prospective Cohort Study of Pancreatic Cancer Patients Treated With Proton Beam Therapy

Plain-language summary

This prospective cohort study is following patients with pancreatic cancer treated with proton beam therapy. Pancreatic cancer patients scheduled for proton beam therapy who agree to participate are eligible. It is a non-phase observational study and is enrolling by invitation.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Enrolling by invitation

Sponsor

National Cancer Center, Korea

Start date

9/21/2018

Estimated completion

8/31/2028

Countries

South Korea

Related genes

Locations

• Goyang-si, South Korea

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Pancreatic cancer patients scheduled to be proton beam therapy
* Agreed to participate in this study

Exclusion Criteria:

-Disagreed to participate in this study